Insider Transactions in Q2 2021 at Alexion Pharmaceuticals, Inc. (ALXN)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 08
2021
|
Indrani Lall Franchini EVP, Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
928
-1.44%
|
$164,256
$177.0 P/Share
|
|
Jun 08
2021
|
Brian Goff EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,086
-1.18%
|
$192,222
$177.0 P/Share
|
|
Jun 08
2021
|
John J Orloff EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,957
-2.22%
|
$346,389
$177.0 P/Share
|
|
May 20
2021
|
David R Brennan Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,336
+7.66%
|
-
|
|
May 20
2021
|
Deborah Dunsire Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,495
+7.87%
|
-
|
|
May 20
2021
|
John T Mollen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,635
+8.0%
|
-
|
|
May 20
2021
|
Francois Nader Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,635
+8.76%
|
-
|
|
May 20
2021
|
Judith A Reinsdorf Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,635
+8.62%
|
-
|
|
May 20
2021
|
Andreas Rummelt Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,495
+4.25%
|
-
|
|
May 20
2021
|
Paul A Friedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,495
+8.87%
|
-
|
|
May 20
2021
|
Christopher J Coughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,691
+3.1%
|
-
|